Siraj, A.K.; Parvathareddy, S.K.; Pratheeshkumar, P.; Divya, S.P.; Al-Sobhi, S.S.; Al-Dayel, F.; Al-Kuraya, K.S.
PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation. Cancers 2021, 13, 555.
https://doi.org/10.3390/cancers13030555
AMA Style
Siraj AK, Parvathareddy SK, Pratheeshkumar P, Divya SP, Al-Sobhi SS, Al-Dayel F, Al-Kuraya KS.
PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation. Cancers. 2021; 13(3):555.
https://doi.org/10.3390/cancers13030555
Chicago/Turabian Style
Siraj, Abdul K., Sandeep Kumar Parvathareddy, Poyil Pratheeshkumar, Sasidharan Padmaja Divya, Saif S. Al-Sobhi, Fouad Al-Dayel, and Khawla S. Al-Kuraya.
2021. "PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation" Cancers 13, no. 3: 555.
https://doi.org/10.3390/cancers13030555
APA Style
Siraj, A. K., Parvathareddy, S. K., Pratheeshkumar, P., Divya, S. P., Al-Sobhi, S. S., Al-Dayel, F., & Al-Kuraya, K. S.
(2021). PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation. Cancers, 13(3), 555.
https://doi.org/10.3390/cancers13030555